PET-CT Scanner Device Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Stationary Scanners, Portable Scanners/ Mobile Scanners), By Applications (Hospitals, Diagnostic Centers, Research Institutes), Regional Insights and Forecast to 2035

PET-CT Scanner Device Market Size

PET-CT Scanner Device Market size stood at USD 2520.1 Million in 2025 and is projected to touch USD 2679.84 Million in 2026 and USD 2849.8 Million in 2027, before reaching USD 4660.67 Million by 2035, exhibiting a CAGR of 6.34% during the forecast period 2026-2035.

Demand for hybrid imaging is anchored in oncology, where a single scan combines metabolic and anatomical information and helps clinicians stage disease with greater confidence. About 62% of PET-CT procedures are linked to cancer diagnosis and treatment monitoring, while nearly 21% support neurology and cardiology. Hospitals are also replacing older systems with digital detector models that improve image quality and shorten scan times.

In the US PET-CT Scanner Device Market, high cancer screening rates and broad reimbursement for imaging procedures sustain steady equipment demand. Roughly 64% of installed systems serve hospital oncology departments, and about 29% of units in operation are due for technology upgrades.

Key Findings

• Market Size: Starting at $2679.84M in 2026, projected to touch $2849.8M in 2027 to $4660.67M by 2035 at a CAGR of 6.34%.
• Growth Drivers: About 62% of scans support oncology, and 34% of centers plan upgrades to digital detector systems.
• Trends: Digital detector systems represent 46% of new installations, while 31% of sites adopt AI-assisted image reconstruction.
• Key Players: Siemens AG, General Electric Co, Toshiba Corporation, Hitachi, Shimadzu Corporation & more.
• Regional Insights: North America leads with 37% share, Europe holds 27%, Asia-Pacific 29%, and Middle East & Africa 7%, completing 100% of demand.
• Challenges: Isotope supply and cyclotron access limit about 28% of centers, while 33% cite high capital cost as a barrier.
• Industry Impact: Faster scan protocols cut patient throughput time by about 24%, and 18% of providers report fewer repeat scans after upgrades.
• Recent Developments: Capacity expansions of 8% to 13% and a 22% rise in digital system launches shaped recent activity.

The PET-CT Scanner Device Market is shaped by clinical value more than unit volume. About 57% of purchase decisions are driven by image quality and quantification accuracy, which favors vendors with strong detector technology and software ecosystems.

Competition is concentrated among established imaging groups. The five largest manufacturers hold close to 68% of the market, and service contracts, often covering more than 7 years, provide recurring revenue while making supplier switching difficult for hospitals.

PET-CT Scanner Device Market Trends

The clearest shift in the PET-CT Scanner Device Market is the move from conventional photomultiplier detectors to digital silicon-based detectors. Digital systems now account for about 46% of new installations because they offer higher sensitivity and better timing resolution, which allows lower tracer doses and shorter scans. Some providers report scan time reductions of roughly 30% when upgrading, which improves patient comfort and daily throughput without adding staff.

Software is becoming as important as hardware. About 31% of new systems include AI-assisted reconstruction and noise reduction, helping clinicians read lower-dose images with confidence. Tracer diversity is also widening the use base, as prostate-specific and neurology tracers contribute to around 19% of newly reported procedure growth. Meanwhile, total-body and extended field-of-view designs are drawing interest in research settings, representing nearly 9% of premium system inquiries, and mobile units are expanding reach to smaller regional hospitals.

PET-CT Scanner Device Market Dynamics

OPPORTUNITY

Growth in emerging-market imaging access and theranostics

Many emerging markets have only a fraction of the PET-CT capacity per capita found in developed regions, and around 38% of mid-sized cities with cancer centers still lack on-site hybrid imaging. Expanding access creates room for refurbished, mobile and mid-range systems. Theranostics adds further potential, as about 27% of oncology centers are evaluating radioligand therapy programs that depend on PET-based patient selection and dosimetry. Vendors that offer flexible financing and training can secure long-term service and software relationships.

DRIVERS

Rising demand for accurate cancer diagnosis and staging

Cancer incidence continues to climb as populations age, and clinicians increasingly rely on hybrid imaging to guide treatment plans. About 62% of PET-CT scans are linked to oncology, and nearly 41% of treatment plans in major cancer centers are adjusted after imaging results. Early and precise staging reduces unnecessary procedures and supports targeted therapy, which strengthens the case for investing in advanced scanners across hospitals and specialty clinics.

RESTRAINTS

"High capital cost and tracer supply constraints"

PET-CT systems require heavy upfront investment, shielded rooms, trained staff and access to short-lived radiotracers. About 33% of mid-sized hospitals cite capital cost as the main barrier to purchase, and roughly 28% of centers face supply limitations tied to cyclotron proximity. Operating costs add pressure, since service contracts and tracer purchases can account for around 15% of annual running costs. Reimbursement variation across regions also slows procurement, pushing some providers toward alternative imaging or shared-access models.

CHALLENGES

"Skilled workforce shortage and radiation management"

Operating a PET-CT facility requires nuclear medicine physicians, technologists and physicists, and about 26% of centers report difficulty recruiting qualified staff. Radiation safety rules add compliance work, and handling short-lived isotopes demands precise scheduling, with scan cancellations affecting roughly 7% of appointments when tracer delivery is delayed. Technology also changes quickly, so around 31% of providers worry about equipment becoming outdated before the investment is fully recovered, which complicates long-term planning.

Segmentation Analysis

The PET-CT Scanner Device Market is segmented by system format and by the care setting in which scanners are used. Format segmentation is strongly tilted toward stationary scanners, which account for about 91% of installed demand because of their image quality and throughput. Application segmentation shows hospitals as the main buyers at nearly 68%, with diagnostic centers and research institutes sharing the remainder. These splits shape product design, service models and pricing across both mature and developing healthcare systems.

By Type

Stationary Scanners

Stationary Scanners dominate with about 91% of the PET-CT Scanner Device Market. Fixed installations offer superior detector coverage, higher throughput and better integration with shielded imaging suites. About 73% of new purchases in large hospitals are digital stationary systems, chosen for sensitivity and low-dose performance. Higher cost and space needs are offset by strong utilization, since busy centers can complete well over 15 scans a day on a single system.

Portable Scanners/ Mobile Scanners

Portable and mobile scanners hold roughly 9% of the market and serve regions that lack permanent imaging sites. Truck-mounted units rotate between smaller hospitals, and about 42% of mobile deployments support oncology screening in underserved areas. They lower entry cost for providers and improve patient access, though limited scan capacity and weather-related logistics keep adoption selective compared with fixed systems.

By Application

Hospitals

Hospitals account for about 68% of demand, supported by integrated oncology, neurology and cardiology services. Around 64% of hospital-based systems are used primarily for cancer staging and response assessment. Large teaching hospitals often operate multiple scanners, and purchasing is influenced by multidisciplinary tumor boards that value consistent, high-quality imaging across departments.

Diagnostic Centers

Diagnostic Centers represent about 23% of the PET-CT Scanner Device Market and are growing as private providers invest in specialty imaging. Roughly 47% of centers in this group operate as part of multi-site chains that negotiate bundled equipment and service contracts. Referral partnerships with oncologists are essential, and faster scan protocols help these centers maximize daily patient volume and profitability.

Research Institutes

Research Institutes hold about 9% of consumption, focusing on tracer development, clinical trials and advanced imaging techniques. Nearly 36% of research systems are configured with extended field-of-view or high-sensitivity detectors. Funding cycles drive purchasing, and partnerships with manufacturers often provide early access to new software, which helps vendors refine products before wider commercial release.

PET-CT Scanner Device Market Regional Outlook

Regional demand in the PET-CT Scanner Device Market reflects healthcare spending, cancer prevalence and imaging infrastructure. North America leads with 37% share thanks to broad access and strong reimbursement. Asia-Pacific follows with 29%, Europe holds 27%, and Middle East & Africa accounts for 7%, bringing the total to 100%. Mature regions focus on upgrades and software, while emerging regions add growth through new installations and expanding cancer care programs.

North America

North America holds about 37% of the PET-CT Scanner Device Market, supported by high imaging utilization and well-established oncology networks. Roughly 64% of regional systems are located in hospitals, and about 29% of installed scanners are due for replacement with digital models. Theranostics programs are expanding quickly, and nearly 33% of cancer centers have launched or planned radioligand therapy services that rely on PET imaging.

Europe

Europe accounts for roughly 27% of the market, shaped by public healthcare systems and strong cancer screening programs. Germany, France and the UK together contribute about 56% of regional demand. About 44% of new installations in the region are digital systems, and tender-based purchasing places emphasis on lifetime service value. Regulatory focus on radiation dose reduction encourages adoption of systems with low-dose protocols.

Asia-Pacific

Asia-Pacific holds about 29% of the market and is the fastest-expanding region by new installations. China and Japan together account for nearly 63% of regional demand, while India and Southeast Asia are adding capacity as private hospital chains grow. About 37% of regional purchases are mid-range systems, reflecting price sensitivity, and local manufacturers are gaining share by offering competitive pricing and faster service response.

Middle East & Africa

Middle East & Africa accounts for about 7% of the PET-CT Scanner Device Market, with demand concentrated in Gulf countries and major urban centers in South Africa and North Africa. Gulf states contribute nearly 52% of regional installations, supported by national investment in specialty hospitals. Imported systems represent about 88% of the regional installed base, and limited tracer supply outside large cities restricts wider access despite growing cancer care needs.

List of Key PET-CT Scanner Device Market Companies Profiled

Investment Analysis and Opportunities

Investment in the PET-CT Scanner Device Market is concentrated on detector technology, software intelligence and service networks. About 38% of recent manufacturer spending supports digital detector development, while roughly 24% funds AI-based reconstruction and workflow tools. Service contracts provide stable income, as nearly 41% of vendor revenue comes from maintenance and upgrades over the life of a system. Opportunities are strongest in theranostics-ready systems, mid-range scanners for emerging markets and mobile units. Local assembly and training centers can reduce delivery times by about 14% and strengthen customer relationships in fast-growing regions.

New Products Development

New product development focuses on sensitivity, speed and ease of use. About 36% of recent launches feature digital silicon-based detectors, and nearly 29% include AI-driven reconstruction that supports lower tracer doses. Extended axial field-of-view designs represent around 12% of premium introductions, allowing faster scans and improved dynamic imaging. Manufacturers are also developing compact and lower-cost models, which account for about 18% of new releases and target mid-sized hospitals. Workflow tools such as automated patient positioning and protocol selection are reducing technologist workload and improving consistency across sites.

Recent Developments

• March 2024– Siemens AG expanded its digital PET-CT system range: The company introduced new configurations with improved timing resolution, and internal testing indicated scan times could be reduced by about 25%, strengthening its premium offering in the PET-CT Scanner Device Market.

• July 2024– General Electric Co launched AI-enhanced image reconstruction software: The software was designed to lower noise in reduced-dose scans, with reported image quality improvement of around 20%, helping providers adopt lower tracer doses without losing diagnostic confidence.

• November 2024– Hitachi upgraded its hybrid imaging service network: The company increased field service coverage across key regions by about 15%, shortening response times for installed systems and supporting customers who rely on high equipment uptime.

• April 2025– Mediso Ltd introduced a compact PET-CT platform for mid-sized hospitals: The new model reduces required room space by roughly 18% and targets facilities with limited infrastructure, widening access to hybrid imaging in emerging healthcare markets.

• September 2025– Shimadzu Corporation expanded production capacity for PET detector modules: The investment raised output by nearly 12%, helping the company meet growing demand from Asia-Pacific hospitals and research institutes upgrading to digital imaging technology.

Report Coverage

This report examines the PET-CT Scanner Device Market through a structured review of demand patterns, competitive positioning and product development. It evaluates segmentation by type, covering Stationary Scanners at 91% and Portable Scanners/ Mobile Scanners at 9%, and by application, covering Hospitals at 68%, Diagnostic Centers at 23% and Research Institutes at 9%. Regional analysis spans North America at 37%, Asia-Pacific at 29%, Europe at 27% and Middle East & Africa at 7%. The study profiles fourteen leading manufacturers, highlights the share held by the two largest suppliers at roughly 49% combined, and reviews drivers, restraints, opportunities and challenges within a consistent analytical framework. It also assesses technology themes such as digital detectors, AI-assisted reconstruction and theranostics readiness, along with service models where maintenance and upgrades contribute about 41% of vendor activity, giving readers a practical view of how the industry is positioned.